Hepatitis E

Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.

Vaccin chinois contre l'hépatite E : l'OMS envisage son utilisation en cas d'épidémie dans un pays en développement

L'hépatite E
L'hépatite E est une maladie du foie provoquée par le virus de l'hépatite E (VHE), un virus à acide ribonucléique (ARN) non enveloppé qui appartient à la famille des Hepeviridæ. Quatre génotypes infectant les hôtes mammifères (génotypes 1, 2, 3 et 4) sont connus, appartenant tous à un sérotype unique.
L'hépatite E est l'une des principales causes d'hépatite virale aiguë dans les pays en développement. 

Protection Without a Vaccine

Last month, a team of scientists announced what could prove to be an enormous step forward in the fight against H.I.V.
Scientists at Scripps Research Institute said they had developed an artificial antibody that, once in the blood, grabbed hold of the virus and inactivated it. The molecule can eliminate H.I.V. from infected monkeys and protect them from future infections.

Chinese Researchers Report Successful Hepatitis E Vaccine

A new vaccine for hepatitis E provides protection from the virus for at least 4.5 years, according to Chinese researchers.
Although hepatitis E is relatively rare in the United States, it's a leading cause of serious liver problems in the developing world. Hepatitis E is spread through contaminated water and through person-to-person contact, the researchers said.

de nouvelles armes pour lutter contre les hépatites

Les hépatites virales sont des maladies du foie silencieuses qui passent souvent inaperçues. Elles peuvent dans certains cas (hépatite B ou C) devenir une maladie chronique pouvant entraîner des complications graves comme la cirrhose ou le cancer du foie. C'est ce qui en fait la gravité."

FDA clears syringe that prevents needlestick injuries

Exton, PA's West Pharmaceutical Services just announced that the FDA has given it 510(k) clearance for the NovaGuard Staked-needle Automatic safety system, as the push to avoid needlestick injuries gathers momentum.
The company says that the device shields the syringe's exposed needle after it has been activated and contains a tamper-evident safety mechanism to prevent early activation of the device.


From the US Centers for Disease Control and Prevention (US CDC) website:

ECDC warns hepatitis underreported, underdiagnosed in Europe

The European Centre for Disease Prevention and Control (ECDC) said on Friday that viral hepatitis in Europe is both underdiagnosed and underreported.
The announcement, made before World Hepatitis Day on July 28, said that hepatitis could lead to other conditions, according to an ECDC press release.

What's the world's biggest health risk?

Infectious diseases can break out suddenly, almost anywhere in the world, and with devastating impact.
The past week has seen Ebola infecting key medical staff in Sierra Leone, a deadly Middle East virus become airborne and a whole city in China put on lock-down for fear of bubonic plague.
The World Health Organisation (WHO), a UN body that exists to protect and advise the international community about threats such as these, raised concerns in May about the "striking changes in the communicable disease situation".

WHO welcomes global momentum on viral hepatitis

On World Hepatitis Day, 28 July, WHO welcomes new progress in tackling one of the world’s most serious diseases. Viral hepatitis – a group of infectious diseases known as hepatitis A, B, C, D, and E – affects millions of people worldwide, causing acute and chronic liver disease and killing close to 1.4 million people every year.
“For years, viral hepatitis has been largely neglected,” says Dr Margaret Chan, Director-General at WHO. “But now we are beginning to see greater awareness and global momentum building to tackle it.”